<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Drug Des Devel Ther</journal-id>
      <journal-id journal-id-type="iso-abbrev">Drug Des Devel Ther</journal-id>
      <journal-title-group>
        <journal-title>Drug Design, Development and Therapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1177-8881</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23378740</article-id>
      <article-id pub-id-type="pmc">3556858</article-id>
      <article-id pub-id-type="doi">10.2147/DDDT.S38324</article-id>
      <article-id pub-id-type="publisher-id">dddt-7-033</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Malagola</surname>
            <given-names>Romualdo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arrico</surname>
            <given-names>Loredana</given-names>
          </name>
          <xref ref-type="corresp" rid="c1-dddt-7-033"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Giannotti</surname>
            <given-names>Rossella</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pattavina</surname>
            <given-names>Luigi</given-names>
          </name>
        </contrib>
        <aff id="af1-dddt-7-033">Department of Ophthalmology, University of Rome &#x201C;La Sapienza,&#x201D; Rome, Italy</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-dddt-7-033">Correspondence: Loredana Arrico, Department of Ophthalmology, University of Rome &#x201C;Sapienza,&#x201D; Viale del Policlinico 155m, 00161 Rome, Italy, Tel +39 335 690 0888, Email <email>loredana.arrico@uniroma1.it</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <volume>7</volume>
      <fpage>33</fpage>
      <lpage>36</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2013 Malagola et al, publisher and licensee Dove Medical Press Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license>
          <license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Idiosyncratic reactions to a large number of drugs have been reported to cause choroidal detachment and secondary angle-closure glaucoma (ACG). We report a case of bilateral acute ACG and peculiar choroidal effusion following administration of oral acetazolamide immediately after cataract surgery. Few cases of acute secondary ACG with choroidal effusion and anterior shift of the lens-iris diaphragm have been associated with acetazolamide compared with other sulfonamides. As far as we are aware, posterior involvement with retinal folds and papillary edema due to acetazolamide has not been described before.</p>
      </abstract>
      <kwd-group>
        <kwd>acetazolamide</kwd>
        <kwd>cilio-choroidal effusion</kwd>
        <kwd>acute ACG</kwd>
        <kwd>papillary edema</kwd>
        <kwd>retinal folds</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Acetazolamide, a sulfonamide-derived medication, is frequently used in patients after cataract surgery.<xref ref-type="bibr" rid="b1-dddt-7-033">1</xref></p>
      <p>It is a member of the class of antihypertensive drugs and is specifically indicated in the treatment of glaucoma, epilepsy, benign intracranial hypertension (pseudotumor cerebri), altitude sickness, cystinuria, and ectasia.<xref ref-type="bibr" rid="b2-dddt-7-033">2</xref>&#x2013;<xref ref-type="bibr" rid="b4-dddt-7-033">4</xref> Acetazolamide acts as an inhibitor of the enzyme carbonic anhydrase and is therefore applied in ophthalmology to control primary or postsurgical secondary ocular hypertension.<xref ref-type="bibr" rid="b5-dddt-7-033">5</xref></p>
      <p>This medication and other sulfa drugs have been documented to cause, very rarely, idiosyncratic reactions characterized by transient myopia, ciliary body edema, uveal effusions, and anterior rotation of the lens-iris diaphragm, which causes secondary angle-closure glaucoma (ACG).<xref ref-type="bibr" rid="b6-dddt-7-033">6</xref> Unfortunately, the angle closure occurs without pupillary block, so that topical miotics and peripheral iridectomy are not helpful.<xref ref-type="bibr" rid="b7-dddt-7-033">7</xref> In contrast, stopping the offending agent and controlling the intraocular pressure (IOP) with the administration of drugs allows rapid resolution of signs and symptoms. This reaction has been frequently documented after topiramate administration, an antiepileptic agent also used to treat migraine,<xref ref-type="bibr" rid="b8-dddt-7-033">8</xref>,<xref ref-type="bibr" rid="b9-dddt-7-033">9</xref> while only rarely after acetazolamide.<xref ref-type="bibr" rid="b10-dddt-7-033">10</xref>&#x2013;<xref ref-type="bibr" rid="b12-dddt-7-033">12</xref></p>
      <p>Here, we report a case of ciliary body edema after administration of acetazolamide causing bilateral ACG, as already described in the literature.<xref ref-type="bibr" rid="b11-dddt-7-033">11</xref>,<xref ref-type="bibr" rid="b12-dddt-7-033">12</xref> However, in our case we found a massive choroidal effusion with posterior retinal folds and papillary edema. The existent literature reporting ciliary body edema after administration of acetazolamide do not describe these features at the posterior pole.<xref ref-type="bibr" rid="b6-dddt-7-033">6</xref>&#x2013;<xref ref-type="bibr" rid="b13-dddt-7-033">13</xref></p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>A 71-year-old white male had routine cataract surgery and intraocular lens implantation under local anesthetic in his right eye (RE) in the late afternoon. He was prescribed a single oral dose of acetazolamide (250 mg) before sleeping to prevent rise of IOP. The patient took the acetazolamide pill at 11 pm (4 hours after cataract surgery). About 3 hours later, he woke up because of severe pain and found he had reduced vision in both eyes, so was referred to our first-aid hospital.</p>
      <p>Upon examination, the patient&#x2019;s best-corrected visual acuity was 3/50 in the RE and 2/50 in left eye (LE), with corrections of &#x2212;4.50 D in the RE and &#x2212;1.25 D in the LE. Both eyes showed congestion and edema of the inferior bulbar conjunctiva, heavy cloudy cornea, and a very shallow anterior chamber (<xref ref-type="fig" rid="f1-dddt-7-033">Figure 1</xref>). The intraocular lens was shifted forward. IOP was 52 mmHg in the RE and 60 mmHg in the LE. Gonioscopy revealed 360-degree appositional angle closure with a convex iris configuration in both eyes. Fundus examination was impossible due to opaque media. A diagnosis of ACG was made and the patient was admitted to the hospital. He was immediately administered mannitol 2 mg/kg intravenously and acetazolamide orally, together with topical steroids and &#x3B2;-blockers.</p>
      <p>Later in the morning, his IOP was 32 mmHg in the RE and 36 mm Hg in the LE. Nd:YAG laser iridotomy was performed in the LE, but had a poor effect on anterior chamber depth and ocular hypertension.</p>
      <p>B-scan ultrasonography (<xref ref-type="fig" rid="f2-dddt-7-033">Figure 2</xref>) showed bilateral choroidal effusion with forward displacement of the anterior segment. Fundus examination was characterized by bilateral peripheral choroidal detachment (<xref ref-type="fig" rid="f3-dddt-7-033">Figure 3</xref>) and papillary swelling. Posterior optical coherence tomography scans confirmed papillary edema (<xref ref-type="fig" rid="f4-dddt-7-033">Figure 4</xref>) together with retinal folds and nerve fiber layer thickening.</p>
      <p>Acetazolamide was suspected as the cause of the bilateral angle closure, thus was discontinued. The clinical manifestations gradually improved and, 3 days later, the patient&#x2019;s IOP was 14 mmHg in the RE and 16 mmHg in the LE, his best-corrected visual acuity was 10/10 in the RE and 7/10 in the LE (because of pre-existing lens opacities), and the myopic shift had receded.</p>
      <p>A month later, the patient underwent cataract surgery of the LE without the use of any sulfonamide medication and, as evidenced by optical coherence tomography scans, had no complications.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Few cases of acute secondary ACG with choroidal effusion and anterior shift of the lens-iris diaphragm have been associated with acetazolamide compared with other sulfonamides<xref ref-type="bibr" rid="b6-dddt-7-033">6</xref>,<xref ref-type="bibr" rid="b10-dddt-7-033">10</xref>&#x2013;<xref ref-type="bibr" rid="b12-dddt-7-033">12</xref> and there have been only a few reports of posterior retinal-fold involvement due to topiramate and hydrochlorothiazide.<xref ref-type="bibr" rid="b13-dddt-7-033">13</xref>,<xref ref-type="bibr" rid="b14-dddt-7-033">14</xref> As far as the authors are aware, papillary edema has never been reported associated with sulfa drugs and posterior involvement with retinal folds and papillary edema due to acetazolamide has not been described.</p>
      <p>The retinal folds in our patient were caused by the action of the retinal pigment epithelium inhibiting further progression of fluid from the choroidal space into the retina and inextensible scleral coat. His papillary edema was caused by the absence of any barrier in the prelaminar region that could inhibit the diffusion of fluid from the choroid into the papilla and peripapillary region. This fluid diffusion was also responsible for the nerve fiber layer thickening.</p>
      <p>Acetazolamide can cause a paradoxical adverse reaction, provoking cilio-choroidal effusion and massive involvement of the anterior and posterior segment.<xref ref-type="bibr" rid="b6-dddt-7-033">6</xref>&#x2013;<xref ref-type="bibr" rid="b14-dddt-7-033">14</xref></p>
      <p>Although topical formulations of carbonic anhydrase enzyme inhibitors, such as dorzolamide, have been developed,<xref ref-type="bibr" rid="b15-dddt-7-033">15</xref> we chose to administer oral acetazolamide because of its well-known ability to reduce acute elevated IOP. As acute elevated IOP is sight threatening, this justified the administration of the acetazolamide, with its associated risk of rare ocular and systemic side effects. Indeed, topical dorzolamide acts only on the carbonic anhydrase enzymes present in ciliary processes of the eye, reducing aqueous flow by 17% and IOP by up to 23% as monotherapy.<xref ref-type="bibr" rid="b16-dddt-7-033">16</xref>&#x2013;<xref ref-type="bibr" rid="b19-dddt-7-033">19</xref> In contrast, acetazolamide alone reduces these parameters by 30%<xref ref-type="bibr" rid="b16-dddt-7-033">16</xref>&#x2013;<xref ref-type="bibr" rid="b19-dddt-7-033">19</xref> thanks to its diuretic properties and indirect osmotic effect that leads to vitreous dehydration together with hyperosmotic agents. Furthermore, it has been shown to act on the outward permeability of the blood&#x2013;retina barrier.<xref ref-type="bibr" rid="b20-dddt-7-033">20</xref></p>
      <p>In prescribing acetazolamide, all specialists and general practitioners should be aware of this side effect of the drug and refer patients to ophthalmologists. At the same time, ophthalmologists should be able, by obtaining an accurate case history, to make a correct differential diagnosis between primary acute ACG and this rare secondary pharmacological adverse reaction.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn1-dddt-7-033">
        <p>
          <bold>Disclosure</bold>
        </p>
        <p>The authors declare no conflicts of interest in this work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-dddt-7-033">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fogagnolo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Centofanti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Figus</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients</article-title>
          <source>Ophthalmologica</source>
          <year>2012</year>
          <volume>228</volume>
          <issue>3</issue>
          <fpage>154</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">22572718</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-dddt-7-033">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassamali</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sica</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Acetazolamide: a forgotten diuretic agent</article-title>
          <source>Cardiol Rev</source>
          <year>2011</year>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>276</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">21983315</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-dddt-7-033">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leaf</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Goldfarb</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness</article-title>
          <source>J Appl Physiol</source>
          <year>2007</year>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>1313</fpage>
          <lpage>1322</lpage>
          <pub-id pub-id-type="pmid">17023566</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-dddt-7-033">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Celebisoy</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>G&#xF6;k&#xE7;ay</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sirin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aky&#xFC;rekli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study</article-title>
          <source>Acta Neurol Scand</source>
          <year>2007</year>
          <volume>116</volume>
          <issue>5</issue>
          <fpage>322</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="pmid">17922725</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-dddt-7-033">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scozzafava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Supuran</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Sulfonamides: a patent review (2008 &#x2013; 2012)</article-title>
          <source>Expert Opin Ther Pat</source>
          <year>2012</year>
          <volume>22</volume>
          <issue>7</issue>
          <fpage>747</fpage>
          <lpage>758</lpage>
          <pub-id pub-id-type="pmid">22697257</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-dddt-7-033">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Danesh-Meyer</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Bilateral angle closure glaucoma induced by sulphonamide-derived medications</article-title>
          <source>Clin Experiment Ophthalmol</source>
          <year>2007</year>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">17300572</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-dddt-7-033">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lachkar</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bouassida</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Drug-induced acute angle closure glaucoma</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>2007</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>129</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">17301614</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-dddt-7-033">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desai</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ramchandani</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Bhopale</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Ramchandani</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2006</year>
          <volume>54</volume>
          <issue>3</issue>
          <fpage>195</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">16921218</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-dddt-7-033">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraunfelder</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Fraunfelder</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Keates</surname>
              <given-names>EU</given-names>
            </name>
          </person-group>
          <article-title>Topiramate-associated acute, bilateral, secondary angle-closure glaucoma</article-title>
          <source>Ophthalmology</source>
          <year>2004</year>
          <volume>111</volume>
          <issue>1</issue>
          <fpage>109</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">14711721</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-dddt-7-033">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mancino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Varesi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cerulli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aiello</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nucci</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2011</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>415</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">21241929</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-dddt-7-033">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parthasarathi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Myint</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sadasivam</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dhillon</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Bilateral acetazolamide-induced choroidal effusion following cataract surgery</article-title>
          <source>Eye (Lond)</source>
          <year>2007</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>870</fpage>
          <lpage>872</lpage>
          <pub-id pub-id-type="pmid">17293785</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-dddt-7-033">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senthil</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Garudadri</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Maheshwari</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2010</year>
          <volume>58</volume>
          <issue>3</issue>
          <fpage>248</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">20413935</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-dddt-7-033">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guier</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>Elevated intraocular pressure and myopic shift linked to topiramate use</article-title>
          <source>Optom Vis Sci</source>
          <year>2007</year>
          <volume>84</volume>
          <issue>12</issue>
          <fpage>1070</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="pmid">18091300</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-dddt-7-033">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roh</surname>
              <given-names>YR</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>Acute-onset bilateral myopia and ciliochoroidal effusion induced by hydrochlorothiazide</article-title>
          <source>Korean J Ophthalmol</source>
          <year>2011</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>214</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">21655050</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-dddt-7-033">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mincione</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scozzafava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Supuran</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents</article-title>
          <source>Curr Pharm Des</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>7</issue>
          <fpage>649</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="pmid">18336310</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-dddt-7-033">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugrue</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>The pharmacology of antiglaucoma drugs</article-title>
          <source>Pharmacol Ther</source>
          <year>1989</year>
          <volume>43</volume>
          <issue>1</issue>
          <fpage>91</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">2675131</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-dddt-7-033">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Supuran</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</article-title>
          <source>Nat Rev Drug Discov</source>
          <year>2008</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>168</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">18167490</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-dddt-7-033">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugrue</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors</article-title>
          <source>Prog Ret Eye Res</source>
          <year>2000</year>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>87</fpage>
          <lpage>112</lpage>
        </element-citation>
      </ref>
      <ref id="b19-dddt-7-033">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maus</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>McLaren</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Brubaker</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans</article-title>
          <source>Arch Ophthalmol</source>
          <year>1997</year>
          <volume>115</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">9006424</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-dddt-7-033">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hikichi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry</article-title>
          <source>Curr Eye Res</source>
          <year>2001</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>166</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">11803477</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-dddt-7-033" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Anterior segment of the left and right eye (which underwent cataract surgery) showing the absence of the anterior chamber, observed during slit lamp examination, and choroidal congestion.</p>
        <p><bold>Abbreviations:</bold> OD, oculus dexter; OS, oculus sinister.</p>
      </caption>
      <graphic xlink:href="dddt-7-033f1"/>
    </fig>
    <fig id="f2-dddt-7-033" position="float">
      <label>Figure 2</label>
      <caption>
        <p>B-scan ultrasonography showing choroidal effusion and chorioretinal detachment.</p>
      </caption>
      <graphic xlink:href="dddt-7-033f2"/>
    </fig>
    <fig id="f3-dddt-7-033" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Choroidal detachment observed during fundus examination using indirect Schepens ophthalmoscopy.</p>
        <p><bold>Abbreviations:</bold> OD, oculus dexter; OS, oculus sinister.</p>
      </caption>
      <graphic xlink:href="dddt-7-033f3"/>
    </fig>
    <fig id="f4-dddt-7-033" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Papillary edema and nerve fiber layer thickening observed during optical coherence tomography examination (right eye).</p>
      </caption>
      <graphic xlink:href="dddt-7-033f4"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
